Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04940416 · ClinicalTrials.gov registry record
Eye Movement Testing for Diagnosing Encephalopathy in Patients With Liver Disease
A clinical trial, sponsored by Stanford University.
- Terminated
- Registry status
- 48
- Enrollment target
NCT04940416: Clinical Trial study, sponsored by Stanford University.
NCT04940416 is a clinical trial that was terminated before completion, run by Stanford University. The registered enrollment target is 48 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04940416 was terminated before completion, sponsored by Stanford University.
- TERMINATED
- Registry status
- 48 participants
- Enrollment target
Study Summary
This study involves utilizing a noninvasive computer application (Neurofit) that performs oculometric assessment of dynamic visual processing in patients with liver cirrhosis to see if the presence of advance liver disease influences eye movement metrics.
Interventions
- DEVICE Neurofit (oculometric testing)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 48 participants |
| Start Date | 2017-08-31 |
| Est. Completion | 2021-06-17 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04940416
The ClinicalTrials.gov registry entry for NCT04940416 describes a study currently listed as terminated, categorized as an unspecified phase. The registered enrollment target is 48 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Stanford University, which has 1,744 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Neurofit (oculometric testing) is the first listed.
NCT04940416 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04940416 about?
NCT04940416 is a clinical study titled "Eye Movement Testing for Diagnosing Encephalopathy in Patients With Liver Disease". This study involves utilizing a noninvasive computer application (Neurofit) that performs oculometric assessment of dynamic visual processing in patients with liver cirrhosis to see if the presence of advance liver disease influences eye movement metrics.
What is the current status of trial NCT04940416?
This trial is currently terminated. The enrollment target is 48 participants. The study started on 2017-08-31. Estimated completion is 2021-06-17.
What interventions are being tested in trial NCT04940416?
The interventions under investigation include: Neurofit (oculometric testing) (DEVICE).
Who is sponsoring clinical trial NCT04940416?
This trial is sponsored by Stanford University, which has 1,744 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.